Table 3 GAGE applied to the BMP6-MSC dataset of small sample size
From: GAGE: generally applicable gene set enrichment for pathway analysis
Experimental Sets | t-statistic | p-value | q-value | P.exp1 | P.exp2 |
|---|---|---|---|---|---|
Ifna_Hcmv_6hrs_Up | -3.80 | 2.9E-07 | 2.9E-04 | 3.7E-04 | 1.6E-04 |
Der_Ifnb_Up | -3.47 | 1.6E-06 | 8.1E-04 | 3.3E-03 | 1.1E-04 |
Baf57_Bt549_Dn | -3.09 | 1.4E-05 | 0.005 | 7.2E-03 | 5.2E-04 |
Ifn_Beta_Up | -2.92 | 5.4E-05 | 0.012 | 1.2E-02 | 1.3E-03 |
Sana_Ifng_Endothelial_Up | -2.88 | 6.6E-05 | 0.014 | 1.2E-02 | 1.7E-03 |
Ifn_Any_Up | -2.76 | 1.1E-04 | 0.019 | 2.4E-02 | 1.4E-03 |
Dac_Bladder_Up | -2.65 | 2.8E-04 | 0.036 | 2.4E-03 | 4.0E-02 |
Grandvaux_Ifn_Not_Irf3_Up | -2.76 | 2.8E-04 | 0.037 | 3.8E-02 | 2.6E-03 |
Ifna_Uv-Cmv_Common_Hc | -2.55 | 5.1E-04 | 0.056 | 1.6E-02 | 1.1E-02 |
Bennett_Sle_Up | -2.48 | 7.3E-04 | 0.071 | 1.4E-02 | 2.0E-02 |
Canonical Pathways | t-statistic | p-value | q-value | P.exp1 | P.exp2 |
Tgf_Beta_Signaling_Pathway | 3.15 | 2.2E-05 | 0.009 | 1.2E-03 | 1.3E-03 |
Wnt_Signaling | 2.47 | 5.9E-04 | 0.099 | 3.2E-03 | 1.7E-02 |
Alkpathway | 2.46 | 8.8E-04 | 0.11 | 9.8E-03 | 8.7E-03 |
Proliferation_Genes | 2.27 | 1.3E-03 | 0.13 | 6.8E-03 | 1.9E-02 |
Cell_Proliferation | 2.24 | 1.5E-03 | 0.15 | 2.1E-02 | 7.5E-03 |
Hematopoesis_Related_Trans | 2.05 | 3.9E-03 | 0.31 | 1.8E-02 | 2.5E-02 |
Erythpathway | 1.98 | 7.5E-03 | 0.46 | 2.7E-02 | 3.5E-02 |
Smooth_Muscle_Contraction | 1.79 | 1.0E-02 | 0.54 | 2.7E-02 | 5.2E-02 |
Apoptosis | 1.73 | 1.3E-02 | 0.60 | 7.1E-02 | 2.5E-02 |
Breast_Cancer_Estrogen_Signaling | 1.61 | 2.0E-02 | 0.69 | 8.1E-02 | 3.6E-02 |